Oncology Central

Vaccine therapy + dasatinib for the treatment of patients with stage IIIB–IV melanoma


Melanoma remains a significant health concern worldwide, with disease incidence continuing to rise over the past four decades. In the USA alone in 2016, the American Cancer Society estimates that 76,380 new cases of melanoma will be diagnosed, with 10,130 patients succumbing to this disease. Although early stages of the disease are surgically curable and adjuvant therapy of high-risk disease is moderately effective in preventing recurrence, advanced-stage, metastatic melanoma has historically exhibited poor durable response rates to existing therapy options and high disease-associated fatality rates.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.